{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:14:34Z","timestamp":1788621274987,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trim.2026.102447","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:17:05Z","timestamp":1787239025000},"page":"102447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Post-transplant Epstein\u2013Barr virus\u2013associated lymphoproliferative disorder after cardiac transplantation: a scoping review"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5079-989X","authenticated-orcid":false,"given":"Jacob","family":"Calpey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7816-0931","authenticated-orcid":false,"given":"Ryan","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9786-8863","authenticated-orcid":false,"given":"Sofia Valencia","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7964-7734","authenticated-orcid":false,"given":"Christopher J.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-0054","authenticated-orcid":false,"given":"Regina","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1062-809X","authenticated-orcid":false,"given":"Jacob","family":"Kalathoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-4339","authenticated-orcid":false,"given":"Michelle","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-2863","authenticated-orcid":false,"given":"Lea","family":"Sacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.trim.2026.102447_bb0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults. Longo DL, ed","volume":"378","author":"Dierickx","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.trim.2026.102447_bb0010","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.trim.2026.102447_bb0015","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/TP.0000000000004577","article-title":"Screening and management of PTLD","volume":"107","author":"Zaffiri","year":"2023","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka","year":"2016","journal-title":"Nat Rev Dis Primer."},{"issue":"19","key":"10.1016\/j.trim.2026.102447_bb0025","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.trim.2026.102447_bb0030","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score","volume":"31","author":"Caillard","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.trim.2026.102447_bb0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jchf.2023.10.018","article-title":"Temporal trends, risk factors, and clinical outcomes of De novo lymphoproliferative disorders after heart transplantation","volume":"12","author":"Kim","year":"2024","journal-title":"JACC Heart Fail"},{"issue":"7","key":"10.1016\/j.trim.2026.102447_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIR.0000000000001155","article-title":"Dual-organ transplantation: indications, evaluation, and outcomes for heart-kidney and heart-liver transplantation: a scientific statement from the American Heart Association","volume":"148","author":"Kittleson","year":"2023","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.trim.2026.102447_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jchf.2017.08.021","article-title":"Cardiac transplantation","volume":"5","author":"Kittleson","year":"2017","journal-title":"JACC Heart Fail."},{"issue":"6","key":"10.1016\/j.trim.2026.102447_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/HHF.0000000000000021","volume":"10","author":"Jessup","year":"2017","journal-title":"Circ. Heart Fail."},{"issue":"8","key":"10.1016\/j.trim.2026.102447_bb0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2008.05.020","article-title":"The changing face of heart transplantation","volume":"52","author":"Hunt","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.trim.2026.102447_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14440","article-title":"Impact of induction therapy on outcomes after heart transplantation","volume":"35","author":"Tzani","year":"2021","journal-title":"Clin. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2026.102447_bb0065","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.healun.2022.01.008","article-title":"The impact of induction therapy on mortality and treated rejection in cardiac transplantation: a retrospective study","volume":"41","author":"Bellumkonda","year":"2022","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.trim.2026.102447_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2025.107308","article-title":"Incidence and risk factors for malignancy after heart transplantation- analysis of the UNOS registry","volume":"293","author":"Magod","year":"2026","journal-title":"Am. Heart J."},{"issue":"11","key":"10.1016\/j.trim.2026.102447_bb0075","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/01.TP.0000144333.19106.58","article-title":"Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn international transplant tumor registry","volume":"78","author":"Aull","year":"2004","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.trim.2026.102447_bb0080","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.healun.2015.05.021","article-title":"Post-transplant lymphoproliferative disease in heart and lung transplantation: defining risk and prognostic factors","volume":"34","author":"Kumarasinghe","year":"2015","journal-title":"J. Heart Lung Transplant."},{"issue":"9506","key":"10.1016\/j.trim.2026.102447_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.trim.2026.102447_bb0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/ejh.13815","article-title":"Early- and late-onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients","volume":"109","author":"Abdulovski","year":"2022","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/TP.0b013e318277e344","article-title":"Characteristics of early and late PTLD development in Pediatric solid organ transplant recipients","volume":"95","author":"Schober","year":"2013","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2026.102447_bb0100","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/TP.0000000000004919","article-title":"Mechanistic understanding of EBV+lymphoproliferative disease development after transplantation","volume":"108","author":"Furlano","year":"2024","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.trim.2026.102447_bb0105","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/TP.0000000000001767","article-title":"The immune response to Epstein Barr virus and implications for posttransplant lymphoproliferative disorder","volume":"101","author":"Martinez","year":"2017","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.trim.2026.102447_bb0110","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajt.2024.02.028","article-title":"The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch","volume":"24","author":"Attieh","year":"2024","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2026.102447_bb0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein\u2013Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation","volume":"14","author":"Choquet","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102447_bb0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0125","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.athoracsur.2021.08.038","article-title":"Epstein-Barr virus predicts malignancy after Pediatric heart transplant, induction therapy and tacrolimus don\u2019t","volume":"114","author":"Giuliano","year":"2022","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","article-title":"Post-transplantation lymphoproliferative disease in heart and heart\u2013lung transplant recipients: 30-year experience at Stanford University","volume":"22","author":"Gao","year":"2003","journal-title":"J. Heart Lung Transplant."},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1034\/j.1399-0012.2001.150506.x","article-title":"Malignancies after heart transplantation: presence of Epstein\u2013Barr virus and cytomegalovirus","volume":"15","author":"Mattila","year":"2001","journal-title":"Clin. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2026.102447_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030976","article-title":"Relationship of post-transplant lymphoproliferative disorders (PTLD) subtypes and clinical outcome in pediatric heart transplant recipients: a retrospective single institutional analysis\/experience of 558 patients","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.trim.2026.102447_bb0145","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/j.1600-6143.2012.04197.x","article-title":"A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among Pediatric heart transplant recipients","volume":"12","author":"Chinnock","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2026.102447_bb0150","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/TP.0000000000002146","article-title":"The changing epidemiology of posttransplant lymphoproliferative disorder in adult solid organ transplant recipients over 30 years: a single-center experience","volume":"102","author":"Peters","year":"2018","journal-title":"Transplantation"},{"issue":"9529","key":"10.1016\/j.trim.2026.102447_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(06)68969-1","article-title":"Heart and lung transplantation in children","volume":"368","author":"Webber","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2026.102447_bb0160","doi-asserted-by":"crossref","unstructured":"Allen UD, Preiksaitis JK, the AST Infectious diseases Community of Practice. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin. Transplant. 2019;33(9):e13652. doi:https:\/\/doi.org\/10.1111\/ctr.13652.","DOI":"10.1111\/ctr.13652"},{"key":"10.1016\/j.trim.2026.102447_bb0165","series-title":"Clinical Practice Guidelines in Oncology: B-Cell Lymphomas","author":"NCCN","year":"2025"},{"issue":"6","key":"10.1016\/j.trim.2026.102447_bb0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/QCO.0000000000000787","article-title":"Epstein\u2013Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes","volume":"34","author":"Lindsay","year":"2021","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.trim.2026.102447_bb0175","doi-asserted-by":"crossref","first-page":"604.e1","DOI":"10.1016\/j.cmi.2015.02.002","article-title":"Current preventive strategies and management of Epstein\u2013Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH questionnaire-based cross-sectional survey","volume":"21","author":"San-Juan","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.trim.2026.102447_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bpa.2017.06.003","article-title":"Long-term outcomes and management of the heart transplant recipient","volume":"31","author":"McCartney","year":"2017","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac","year":"2010","journal-title":"Implement. Sci."},{"issue":"3","key":"10.1016\/j.trim.2026.102447_bb0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.11124\/JBIES-22-00123","article-title":"Recommendations for the extraction, analysis, and presentation of results in scoping reviews","volume":"21","author":"Pollock","year":"2023","journal-title":"JBI Evid Synth."},{"issue":"7","key":"10.1016\/j.trim.2026.102447_bb0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12874-020-0897-3","article-title":"Software tools to support title and abstract screening for systematic reviews in healthcare: an evaluation","volume":"20","author":"Harrison","year":"2020","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jjcc.2016.02.010","article-title":"Posttransplant lymphoproliferative disease and survival in adult heart transplant recipients","volume":"69","author":"Hayes","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.trim.2026.102447_bb0210","doi-asserted-by":"crossref","unstructured":"Asleh R, Vucicevic D, Petterson TM, et al. Sirolimus-based immunosuppression is associated with decreased incidence of post-transplant lymphoproliferative disorder after heart transplantation: a double-center study. J. Clin. Med. 2022;11(2):322. doi:https:\/\/doi.org\/10.3390\/jcm11020322.","DOI":"10.3390\/jcm11020322"},{"issue":"11","key":"10.1016\/j.trim.2026.102447_bb0215","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/tri.14012","article-title":"Malignancy among adult heart transplant recipients following patient-tailored dosing of anti-thymocyte globulin: a retrospective, nested case-control study of individualized dosing","volume":"34","author":"Bubik","year":"2021","journal-title":"Transpl. Int."},{"issue":"10","key":"10.1016\/j.trim.2026.102447_bb0220","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1034\/j.1600-6143.2002.21011.x","article-title":"Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients","volume":"2","author":"Tsai","year":"2002","journal-title":"Am. J. Transplant."},{"issue":"21","key":"10.1016\/j.trim.2026.102447_bb0230","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.jacc.2019.03.499","article-title":"Incidence of malignancies in patients treated with sirolimus following heart transplantation","volume":"73","author":"Asleh","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAS.0b013e318181a826","article-title":"Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient","volume":"33","author":"Morovic","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0240","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfx356","article-title":"Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study","volume":"33","author":"Francis","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102447_bb0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2011.03499.x","article-title":"Epstein\u2013Barr virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy","volume":"11","author":"Nourse","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102447_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1399-3062.2001.003002060.x","article-title":"The Epstein\u2013Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis","volume":"3","author":"Tanner","year":"2001","journal-title":"Transpl. Infect. Dis."},{"issue":"7","key":"10.1016\/j.trim.2026.102447_bb0260","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/ndt\/gfz207","article-title":"Post-transplant lymphoproliferative disorder: risk factors and management","volume":"36","author":"Malyszko","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"24","key":"10.1016\/j.trim.2026.102447_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247542","article-title":"Post-transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: biology and treatment options","volume":"11","author":"Clerico","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.trim.2026.102447_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14763","article-title":"Epstein\u2013Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: a prospective multicenter study in the United States","volume":"28","author":"Tajima","year":"2024","journal-title":"Pediatr. Transplant."},{"issue":"12","key":"10.1016\/j.trim.2026.102447_bb0275","first-page":"802","article-title":"Clinical analysis of posttransplant lymphoproliferative disorder after liver transplant","volume":"23","author":"Wang","year":"2025","journal-title":"Exp. Clin. Transplant."},{"issue":"6","key":"10.1016\/j.trim.2026.102447_bb0285","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.healun.2024.12.014","article-title":"Incidence and risk factors for rejection after conversion from calcineurin inhibitor to sirolimus-based immunosuppression in orthotopic heart transplant recipients","volume":"44","author":"Inglis","year":"2025","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.trim.2026.102447_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.trim.2026.102447_bb0295","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ajt.15216","article-title":"Dual blockade of the PI3K\/Akt\/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival","volume":"19","author":"Sang","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2026.102447_bb0300","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.healun.2007.08.010","article-title":"Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish post\u2013heart transplant tumour registry","volume":"26","author":"Crespo-Leiro","year":"2007","journal-title":"J. Heart Lung Transplant."},{"issue":"8","key":"10.1016\/j.trim.2026.102447_bb0305","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"issue":"17","key":"10.1016\/j.trim.2026.102447_bb0310","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1182\/blood.2023020075","article-title":"How I treat posttransplant lymphoproliferative disorder","volume":"142","author":"Amengual","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2026.102447_bb0315","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bjh.18763","article-title":"Post-transplant lymphoproliferative disorder: update on treatment and novel therapies","volume":"201","author":"Atallah-Yunes","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.trim.2026.102447_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14471","article-title":"The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: III \u2013 consensus guidelines for Epstein-Barr virus load and other biomarker monitoring","volume":"28","author":"Preiksaitis","year":"2024","journal-title":"Pediatr. Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742600105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742600105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:55:03Z","timestamp":1788620103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742600105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":63,"alternative-id":["S096632742600105X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102447","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transplant Epstein\u2013Barr virus\u2013associated lymphoproliferative disorder after cardiac transplantation: a scoping review","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102447"}}